enprofylline has been researched along with Chronic Illness in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind crossover study has been performed in 14 patients with moderately severe chronic asthma to compare the bronchodilator efficacy of two dosage regimens of intravenous enprofylline (high dose = 2 mg/kg bolus and 1 mg/kg/hour infusion; low dose = 1 mg/kg bolus and 500 micrograms/kg/hour infusion) with aminophylline (5 mg/kg/bolus and 500 micrograms/kg/hour infusion) and placebo." | 9.06 | Enprofylline in chronic asthma. ( Capewell, S; Chapman, BJ; Crompton, GK; Frame, MH; McDonald, C, 1988) |
| "A double-blind crossover study has been performed in 14 patients with moderately severe chronic asthma to compare the bronchodilator efficacy of two dosage regimens of intravenous enprofylline (high dose = 2 mg/kg bolus and 1 mg/kg/hour infusion; low dose = 1 mg/kg bolus and 500 micrograms/kg/hour infusion) with aminophylline (5 mg/kg/bolus and 500 micrograms/kg/hour infusion) and placebo." | 5.06 | Enprofylline in chronic asthma. ( Capewell, S; Chapman, BJ; Crompton, GK; Frame, MH; McDonald, C, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, BJ | 1 |
| McDonald, C | 1 |
| Capewell, S | 1 |
| Frame, MH | 1 |
| Crompton, GK | 1 |
1 trial available for enprofylline and Chronic Illness
| Article | Year |
|---|---|
Enprofylline in chronic asthma.
Topics: Adult; Aged; Aminophylline; Asthma; Bronchodilator Agents; Chronic Disease; Clinical Trials as Topic | 1988 |